Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report)'s stock price traded down 5.1% on Monday . The company traded as low as $7.82 and last traded at $7.82. 119,301 shares changed hands during mid-day trading, a decline of 4% from the average session volume of 124,084 shares. The stock had previously closed at $8.24.
Shionogi & Co., Ltd. Trading Up 1.6%
The business's fifty day moving average is $7.89 and its 200-day moving average is $7.39. The stock has a market capitalization of $12.95 billion, a PE ratio of 14.55, a P/E/G ratio of 2.37 and a beta of 0.19. The company has a quick ratio of 7.01, a current ratio of 7.64 and a debt-to-equity ratio of 0.01.
Shionogi & Co., Ltd. (OTCMKTS:SGIOY - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.17 by ($0.03). Shionogi & Co., Ltd. had a net margin of 35.53% and a return on equity of 12.02%. The company had revenue of $721.77 million during the quarter, compared to analysts' expectations of $824.23 million. As a group, analysts anticipate that Shionogi & Co., Ltd. will post 0.66 EPS for the current fiscal year.
About Shionogi & Co., Ltd.
(
Get Free Report)
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Further Reading
Before you consider Shionogi & Co., Ltd., you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. wasn't on the list.
While Shionogi & Co., Ltd. currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
